Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal misoprostol versus vaginal misoprostol plus rectal hyoscine butylbromide for labor induction in postdate nulliparous women
PACTR202407560838827Phase 3Not yet recruiting
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol and hyoscine butylbromide in Pregnancy prolongation (2 arms). Primary endpoint: Cervical ripening. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
misoprostolhyoscine butylbromide
03
Conditions
Pregnancy prolongation
Beyond the preview
Go deeper on PACTR202407560838827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407560838827.